Richard Bernstein Advisors Trims Boston Scientific Stake

Asset manager reduces position in medical device company by over 50%

Published on Mar. 10, 2026

Got story updates? Submit your updates here. ›

Richard Bernstein Advisors LLC, a prominent investment management firm, has reduced its stake in Boston Scientific Corporation (NYSE:BSX) by 54.5% in the third quarter, according to a recent SEC filing. The firm now owns 42,704 shares of the medical equipment provider's stock, down from 93,890 shares previously.

Why it matters

This move by a major institutional investor provides insight into the market's sentiment towards Boston Scientific. The reduction in stake could signal concerns about the company's performance or valuation, though it's important to note that investment decisions are complex and can be influenced by a variety of factors.

The details

In its 13F filing, Richard Bernstein Advisors reported selling 51,186 shares of Boston Scientific during the third quarter. The firm's remaining position in the company is valued at $4.17 million. Boston Scientific is a leading medical device manufacturer focused on less-invasive procedures across cardiovascular, digestive, urologic, and other medical fields.

  • Richard Bernstein Advisors reduced its Boston Scientific stake in the 3rd quarter of 2026.

The players

Richard Bernstein Advisors LLC

A prominent investment management firm that has reduced its stake in Boston Scientific Corporation.

Boston Scientific Corporation

A global medical device company that develops and markets a broad portfolio of products used in less-invasive medical procedures.

Got photos? Submit your photos here. ›

The takeaway

This reduction in stake by a major institutional investor like Richard Bernstein Advisors could signal potential concerns about Boston Scientific's outlook, though investment decisions are complex. Investors will likely continue to monitor the company's performance and any further changes in institutional ownership.